CVS Health backs digitizing autism care, leads $20M investment round

CVS Health Ventures led a $20 million series A investment round for SpectrumAI, a company working to create digital tools for clinicians treating autism with applied behavior analysis.

Advertisement

The company will use the financing to accelerate the adoption of Twyll, its EHR system for applied behavioral analysis and Patterns, its analytics platform, according to a March 16 SpectrumAI news release. 

Applied behavior analysis is an intensive, 25- to 40-hour-per-week therapy process; the company said it hopes to modernize it through digital tools. 

“Data collection and documentation is fundamental to creating value-based contracting for the ABA industry and can help ensure that patients get the correct level of support they need,” Vijay Patel, managing partner at CVS Health Ventures, said in the release. “Our investment can help support SpectrumAi’s use of disruptive technology and value-based care to address ABA’s significant data void.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.